Note 9 - Subsequent Events (Details Textual) - Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] - shares |
Aug. 12, 2024 |
Aug. 05, 2024 |
Jun. 30, 2024 |
Mar. 31, 2022 |
Apr. 30, 2020 |
Oct. 31, 2017 |
Apr. 30, 2016 |
|---|---|---|---|---|---|---|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | 5,100,000 | 5,100,000 | 3,100,000 | 1,600,000 | 700,000 | ||
| Subsequent Event [Member] | |||||||
| Stockholders' Equity, Reverse Stock Split | 5 | 5 | |||||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | 1,420,000 | 7,100,000 |
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|